\-\ Texto\\:\\ \ \(0\)\
\-\ subjective\\ headaches\\,\\ without\\ focal\\ neurological\\ finding\\ on\\ examination\\.\ \(0\)\
\-\ surgical\\ resection\\ with\\ uneventful\\ postoperative\\ course\\.\ \(0\)\
\-\ \\â\\€\\¢\\ ct\\:\\ well\\-marginated\\ low\\-density\\ cystic\\ appearing\\ cerebellar\\ mass\\ with\\ a\\ mural\\ nodule\\.\\ \ \(0\)\
\-\ \\â\\€\\¢\\ mri\\:\\ t1\\ hypointense\\ \\/\\ t2\\ hyperintense\\ cystic\\ cerebellar\\ lesion\\ with\\ isointense\\ mural\\ nodule\\.\ \(0\)\
\-\ cerebellar\\ hemangioblastoma\ \(3\)\
\-\ \\â\\€\\¢\\ hemangioblastoma\ \(1\)\
\-\ \\â\\€\\¢\\ pilocytic\\ astrocytoma\ \(1\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ \\â\\€\\¢\\ astrocytoma\ \(1\)\
\-\ \\â\\€\\¢\\ cavernous\\ malformation\ \(0\)\
\-\ \\â\\€\\¢\\ ependymoma\ \(8\)\
\-\ 33\\ y\\/o\\ man\\ with\\ complaints\\ of\\ nonspecific\\ headaches\\,\\ without\\ focal\\ neurological\\ finding\\.\ \(1\)\
\-\ hemangioblastomas\\ are\\ uncommon\\ vascular\\ tumors\\ of\\ the\\ central\\ nervous\\ system\\ that\\ occur\\ mainly\\ in\\ the\\ cerebellum\\ and\\ spinal\\ cord\\.\\ they\\ are\\ benign\\ neoplasms\\ of\\ endothelial\\ origin\\;\\ most\\ commonly\\ seen\\ in\\ young\\ and\\ middle\\ aged\\ adults\\.\\ \\ they\\ are\\ the\\ most\\ common\\ primary\\ cerebellar\\ neoplasm\\ in\\ adults\\ 40\\-60\\ years\\ old\\.\\ \\ among\\ patients\\ with\\ hemangioblastoma\\,\\ 25\\ percent\\ occur\\ in\\ those\\ with\\ von\\ hippel\\-lindau\\ disease\\.\\ on\\ the\\ other\\ hand\\,\\ hemangioblastomas\\ are\\ the\\ most\\ common\\ lesions\\ associated\\ with\\ vhl\\ disease\\,\\ eventually\\ affecting\\ 44\\ to\\ 80\\ percent\\ of\\ patients\\.\\ sporadic\\ hemangioblastoma\\ are\\ usually\\ solitary\\;\\ multiple\\ tumors\\ within\\ the\\ neuraxis\\ should\\ raise\\ suspicion\\ for\\ vhl\\ disease\\.\ \(0\)\
\-\ hemangioblastomas\\ cause\\ neurologic\\ deficits\\,\\ both\\ by\\ direct\\ compression\\ or\\ tumor\\-associated\\ hemorrhage\\.\\ the\\ specific\\ deficit\\ from\\ direct\\ compression\\ depends\\ upon\\ tumor\\ location\\,\\ and\\ may\\ include\\ cerebellar\\ ataxia\\,\\ oculomotor\\ nerve\\ dysfunction\\,\\ motor\\ weakness\\,\\ or\\ sensory\\ deficits\\.\\ patients\\ with\\ spinal\\ hemangioblastomas\\ frequently\\ present\\ with\\ pain\\.\\ \\ secondary\\ to\\ this\\ associated\\ risk\\ of\\ hemorrhage\\,\\ surgical\\ treatment\\ is\\ indicated\\,\\ as\\ in\\ this\\ patient\\.\ \(0\)\
\-\ the\\ diagnostic\\ procedure\\ of\\ choice\\ is\\ gadolinium\\-enhanced\\ magnetic\\ resonance\\ imaging\\ \\(mri\\)\\.\\ \\ the\\ classic\\ appearance\\ is\\ a\\ well\\-defined\\ cystic\\ mass\\ with\\ an\\ intensely\\ enhancing\\ mural\\ nodule\\ \\(60\\%\\ of\\ cases\\)\\.\\ \\ because\\ the\\ tumor\\ nodule\\ receives\\ it\\â\\€\\™s\\ blood\\ supply\\ from\\ the\\ pia\\ mater\\,\\ the\\ nodule\\,\\ which\\ represents\\ the\\ tumor\\ itself\\,\\ is\\ almost\\ always\\ superficial\\.\\ \\ up\\ to\\ 40\\%\\ are\\ entirely\\ solid\\.\\ \\ in\\ these\\ cases\\,\\ the\\ margins\\ can\\ be\\ ill\\-defined\\ and\\ occasionally\\ can\\ see\\ hemorrhage\\.\\ \\ surrounding\\ edema\\ may\\ be\\ present\\.\\ \\ flow\\ voids\\ within\\ the\\ nodule\\ may\\ be\\ present\\.\ \(0\)\
\-\ an\\ acute\\ hemorrhage\\ secondary\\ to\\ hemangioblastoma\\ can\\ be\\ catastrophic\\.\\ \\ intracerebral\\ bleeding\\ from\\ a\\ cerebellar\\ hemangioblastoma\\ may\\ cause\\ rapid\\ obstructive\\ hydrocephalus\\,\\ cerebellar\\ tonsillar\\ herniation\\,\\ brainstem\\ compression\\,\\ or\\ uncal\\ herniation\\.\\ bleeding\\ from\\ a\\ spinal\\ hemangioblastoma\\ may\\ result\\ in\\ acute\\ quadriplegia\\ or\\ paraplegia\\ from\\ hemorrhage\\ into\\ the\\ spinal\\ cord\\.\\ \\ headache\\,\\ back\\ pain\\,\\ or\\ radiculopathy\\ can\\ result\\ from\\ subarachnoid\\ hemorrhage\\.\\ in\\ these\\ situations\\,\\ emergency\\ neurosurgical\\ intervention\\ is\\ indicated\\.\ \(0\)\
\-\ references\\:\ \(0\)\
\-\ brant\\ we\\,\\ helms\\ ca\\.\\ \\ fundamentals\\ of\\ diagnostic\\ radiology\\.\\ lippincott\\,\\ williams\\ \\&\\ wilkins\\.\\ philadelphia\\.\\ 2007\\.\ \(0\)\
\-\ neumann\\,\\ hp\\,\\ eggert\\,\\ hr\\,\\ weigel\\,\\ k\\,\\ friedburg\\,\\ h\\.\\ hemangioblastomas\\ of\\ the\\ central\\ nervous\\ system\\.\\ a\\ 10\\-year\\ study\\ with\\ special\\ reference\\ to\\ von\\ hippel\\-lindau\\ syndrome\\.\\ journal\\ of\\ neurosurgery\\ 1989\\;\\ 70\\:24\\.\ \(0\)\
\-\ osborn\\ ag\\.\\ \\ diagnostic\\ neuroradiology\\.\\ mosby\\.\\ st\\ louis\\.\\ 1994\\.\ \(0\)\
\-\ slater\\ a\\,\\ moore\\ nr\\,\\ hudson\\ sm\\.\\ the\\ natural\\ history\\ of\\ cerebellar\\ hemangioblastomas\\ in\\ von\\ hippel\\-lindau\\ disease\\.\\ american\\ journal\\ of\\ neuroradiology\\.\\ 2003\\;\\ 24\\(8\\)\\:1570\\-4\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hemangioblastomas\\:\\ 0\\.08270008233224424\ \(0\)\
\-\ hemangioblastoma\\:\\ 0\\.061313946256420754\ \(0\)\
\-\ cerebellar\\:\\ 0\\.05470307545890055\ \(0\)\
\-\ nodule\\:\\ 0\\.03920831464833402\ \(0\)\
\-\ hippel\\-lindau\\:\\ 0\\.03239213070730523\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.0316614833117926\ \(0\)\
\-\ von\\:\\ 0\\.029952863930322923\ \(0\)\
\-\ mural\\:\\ 0\\.027073885187672005\ \(0\)\
\-\ vhl\\:\\ 0\\.02606218536081055\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.023258097982870322\ \(0\)\
\-\ neuroradiology\\:\\ 0\\.02319320618369188\ \(0\)\
\-\ spinal\\:\\ 0\\.022707059075173182\ \(0\)\
\-\ nervous\\:\\ 0\\.02107615661609406\ \(0\)\
\-\ diagnostic\\:\\ 0\\.018846972885039278\ \(0\)\
\-\ journal\\:\\ 0\\.017978577033077467\ \(0\)\
\-\ compression\\:\\ 0\\.017803788458070093\ \(0\)\
\-\ may\\:\\ 0\\.01738709062057629\ \(0\)\
\-\ percent\\:\\ 0\\.017278795326927\ \(0\)\
\-\ \\,\\:\\ 0\\.016574085643915555\ \(0\)\
\-\ eggert\\:\\ 0\\.01635532175132931\ \(0\)\
\-\ weigel\\:\\ 0\\.01635532175132931\ \(0\)\
\-\ friedburg\\:\\ 0\\.01635532175132931\ \(0\)\
\-\ 70\\:24\\.\\:\\ 0\\.01635532175132931\ \(0\)\
\-\ moore\\:\\ 0\\.01635532175132931\ \(0\)\
\-\ \\:1570\\-4\\:\\ 0\\.01635532175132931\ \(0\)\
\-\ adults\\:\\ 0\\.016182453164055623\ \(0\)\
\-\ tumor\\-associated\\:\\ 0\\.015069334403351675\ \(0\)\
\-\ gadolinium\\-enhanced\\:\\ 0\\.015069334403351675\ \(0\)\
\-\ pia\\:\\ 0\\.015069334403351675\ \(0\)\
\-\ neumann\\:\\ 0\\.015069334403351675\ \(0\)\
\-\ 10\\-year\\:\\ 0\\.015069334403351675\ \(0\)\
\-\ slater\\:\\ 0\\.015069334403351675\ \(0\)\
\-\ hudson\\:\\ 0\\.015069334403351675\ \(0\)\
\-\ \\;\\:\\ 0\\.01503095501634578\ \(0\)\
\-\ direct\\:\\ 0\\.014977346682207677\ \(0\)\
\-\ deficits\\:\\ 0\\.014509252859102297\ \(0\)\
\-\ can\\:\\ 0\\.014383839350419812\ \(0\)\
\-\ low\\-density\\:\\ 0\\.01431708002838291\ \(0\)\
\-\ oculomotor\\:\\ 0\\.01431708002838291\ \(0\)\
\-\ herniation\\:\\ 0\\.014118304749054704\ \(0\)\
\-\ from\\:\\ 0\\.014097614617672121\ \(0\)\
\-\ mater\\:\\ 0\\.01378334705537404\ \(0\)\
\-\ catastrophic\\:\\ 0\\.01378334705537404\ \(0\)\
\-\ bleeding\\:\\ 0\\.013764649165365185\ \(0\)\
\-\ neurological\\:\\ 0\\.013719942899999048\ \(0\)\
\-\ indicated\\:\\ 0\\.013719942899999048\ \(0\)\
\-\ cystic\\:\\ 0\\.013717807275983812\ \(0\)\
\-\ neuraxis\\:\\ 0\\.01336935159839035\ \(0\)\
\-\ situations\\:\\ 0\\.01336935159839035\ \(0\)\
\-\ hp\\:\\ 0\\.01336935159839035\ \(0\)\
\-\ nr\\:\\ 0\\.01336935159839035\ \(0\)\
\-\ uncal\\:\\ 0\\.013031092680405275\ \(0\)\
\-\ 1994\\.\\:\\ 0\\.013031092680405275\ \(0\)\
\-\ are\\:\\ 0\\.012967056094949183\ \(0\)\
\-\ disease\\:\\ 0\\.012956748990869241\ \(0\)\
\-\ 40\\-60\\:\\ 0\\.01274509884028049\ \(0\)\
\-\ well\\-marginated\\:\\ 0\\.012497359707396405\ \(0\)\
\-\ quadriplegia\\:\\ 0\\.012497359707396405\ \(0\)\
\-\ paraplegia\\:\\ 0\\.012497359707396405\ \(0\)\
\-\ system\\:\\ 0\\.012484155734325781\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.012312987750179206\ \(0\)\
\-\ patients\\:\\ 0\\.012309320590163408\ \(0\)\
\-\ 2007\\.\\:\\ 0\\.01227883830543651\ \(0\)\
\-\ osborn\\:\\ 0\\.01227883830543651\ \(0\)\
\-\ sm\\:\\ 0\\.01227883830543651\ \(0\)\
\-\ result\\:\\ 0\\.012163948634315257\ \(0\)\
\-\ headaches\\:\\ 0\\.012120379736813649\ \(0\)\
\-\ cord\\:\\ 0\\.012048882820799262\ \(0\)\
\-\ tumors\\:\\ 0\\.011909893720484234\ \(0\)\
\-\ 1989\\:\\ 0\\.011906536458567955\ \(0\)\
\-\ occur\\:\\ 0\\.011896276915701443\ \(0\)\
\-\ endothelial\\:\\ 0\\.01174510533242764\ \(0\)\
\-\ brant\\:\\ 0\\.011459111492302856\ \(0\)\
\-\ ag\\:\\ 0\\.011459111492302856\ \(0\)\
\-\ they\\:\\ 0\\.011424660951715421\ \(0\)\
\-\ receives\\:\\ 0\\.011331109875443947\ \(0\)\
\-\ intracerebral\\:\\ 0\\.011331109875443947\ \(0\)\
\-\ tumor\\:\\ 0\\.011088491474642734\ \(0\)\
\-\ intensely\\:\\ 0\\.010992850957458876\ \(0\)\
\-\ helms\\:\\ 0\\.010992850957458876\ \(0\)\
\-\ most\\:\\ 0\\.010980529545796341\ \(0\)\
\-\ tonsillar\\:\\ 0\\.010892540713914765\ \(0\)\
\-\ present\\:\\ 0\\.01074216375101121\ \(0\)\
\-\ cause\\:\\ 0\\.010728247222827333\ \(0\)\
\-\ louis\\:\\ 0\\.01070685711733409\ \(0\)\
\-\ fundamentals\\:\\ 0\\.01062054911059032\ \(0\)\
\-\ cases\\:\\ 0\\.010563305617740751\ \(0\)\
\-\ depends\\:\\ 0\\.01053807830804703\ \(0\)\
\-\ neurosurgical\\:\\ 0\\.01053807830804703\ \(0\)\
\-\ natural\\:\\ 0\\.01053807830804703\ \(0\)\
\-\ subjective\\:\\ 0\\.010459117984450005\ \(0\)\
\-\ aged\\:\\ 0\\.010459117984450005\ \(0\)\
\-\ central\\:\\ 0\\.010432769413209496\ \(0\)\
\-\ st\\:\\ 0\\.010383381445451386\ \(0\)\
\-\ special\\:\\ 0\\.010310615743868304\ \(0\)\
\-\ uneventful\\:\\ 0\\.01024059658249011\ \(0\)\
\-\ sporadic\\:\\ 0\\.01024059658249011\ \(0\)\
\-\ finding\\:\\ 0\\.010219152152276369\ \(0\)\
\-\ h\\.\\:\\ 0\\.01017312414432522\ \(0\)\
\-\ mainly\\:\\ 0\\.01010801965487945\ \(0\)\
\-\ lippincott\\:\\ 0\\.009984287976774309\ \(0\)\
\-\ be\\:\\ 0\\.00977927067416645\ \(0\)\
\-\ entirely\\:\\ 0\\.00970686360948124\ \(0\)\
\-\ wilkins\\:\\ 0\\.00970686360948124\ \(0\)\
\-\ among\\:\\ 0\\.009420869769356455\ \(0\)\
\-\ williams\\:\\ 0\\.009334561762612685\ \(0\)\
\-\ mosby\\:\\ 0\\.009334561762612685\ \(0\)\
\-\ resonance\\:\\ 0\\.009292868152497549\ \(0\)\
\-\ or\\:\\ 0\\.009290563533986156\ \(0\)\
\-\ postoperative\\:\\ 0\\.009212190764854248\ \(0\)\
\-\ magnetic\\:\\ 0\\.009097394097473751\ \(0\)\
\-\ voids\\:\\ 0\\.009060654529206257\ \(0\)\
\-\ focal\\:\\ 0\\.00905563489476216\ \(0\)\
\-\ raise\\:\\ 0\\.009024628395890669\ \(0\)\
\-\ ill\\-defined\\:\\ 0\\.008954609234512474\ \(0\)\
\-\ itself\\:\\ 0\\.008920566305628992\ \(0\)\
\-\ neurosurgery\\:\\ 0\\.008920566305628992\ \(0\)\
\-\ brainstem\\:\\ 0\\.008887136796347585\ \(0\)\
\-\ philadelphia\\:\\ 0\\.008887136796347585\ \(0\)\
\-\ secondary\\:\\ 0\\.008864675200403738\ \(0\)\
\-\ affecting\\:\\ 0\\.008822032306901817\ \(0\)\
\-\ supply\\:\\ 0\\.008822032306901817\ \(0\)\
\-\ eventually\\:\\ 0\\.008728468571044874\ \(0\)\
\-\ k\\:\\ 0\\.0086393976634635\ \(0\)\
\-\ radiculopathy\\:\\ 0\\.00858230738764392\ \(0\)\
\-\ reference\\:\\ 0\\.008526921556197387\ \(0\)\
\-\ ataxia\\:\\ 0\\.008473141339363895\ \(0\)\
\-\ superficial\\:\\ 0\\.008473141339363895\ \(0\)\
\-\ dysfunction\\:\\ 0\\.008446824762384383\ \(0\)\
\-\ pilocytic\\:\\ 0\\.008345139722504988\ \(0\)\
\-\ occasionally\\:\\ 0\\.008345139722504988\ \(0\)\
\-\ we\\:\\ 0\\.008345139722504988\ \(0\)\
\-\ common\\:\\ 0\\.008297837521174016\ \(0\)\
\-\ these\\:\\ 0\\.008251742827301818\ \(0\)\
\-\ 33\\:\\ 0\\.008225402206479807\ \(0\)\
\-\ suspicion\\:\\ 0\\.008225402206479807\ \(0\)\
\-\ sensory\\:\\ 0\\.008202354859543709\ \(0\)\
\-\ choice\\:\\ 0\\.008202354859543709\ \(0\)\
\-\ deficit\\:\\ 0\\.008179590309280603\ \(0\)\
\-\ nonspecific\\:\\ 0\\.008157101699758628\ \(0\)\
\-\ well\\-defined\\:\\ 0\\.008157101699758628\ \(0\)\
\-\ always\\:\\ 0\\.008157101699758628\ \(0\)\
\-\ obstructive\\:\\ 0\\.008157101699758628\ \(0\)\
\-\ 44\\:\\ 0\\.00813488242137882\ \(0\)\
\-\ neoplasms\\:\\ 0\\.008069777931933052\ \(0\)\
\-\ rapid\\:\\ 0\\.008006880804519913\ \(0\)\
\-\ 2003\\:\\ 0\\.007966103612091758\ \(0\)\
\-\ cerebellum\\:\\ 0\\.007887143288494736\ \(0\)\
\-\ solitary\\:\\ 0\\.00786791733852155\ \(0\)\
\-\ \\/\\:\\ 0\\.007830053012675154\ \(0\)\
\-\ acute\\:\\ 0\\.0078288657851818\ \(0\)\
\-\ isointense\\:\\ 0\\.007792946024351093\ \(0\)\
\-\ uncommon\\:\\ 0\\.007756566671125904\ \(0\)\
\-\ hr\\:\\ 0\\.00772088696439513\ \(0\)\
\-\ subarachnoid\\:\\ 0\\.0077033011685610974\ \(0\)\
\-\ almost\\:\\ 0\\.007668621886534839\ \(0\)\
\-\ represents\\:\\ 0\\.0076177889103045725\ \(0\)\
\-\ american\\:\\ 0\\.007552108155108067\ \(0\)\
\-\ hypointense\\:\\ 0\\.0075201196459531395\ \(0\)\
\-\ associated\\:\\ 0\\.0074822358512345154\ \(0\)\
\-\ without\\:\\ 0\\.0074657260347241565\ \(0\)\
\-\ 80\\:\\ 0\\.0074577511658066\ \(0\)\
\-\ \\%\\:\\ 0\\.007396367470671642\ \(0\)\
\-\ ca\\:\\ 0\\.007382628046410057\ \(0\)\
\-\ cavernous\\:\\ 0\\.007353410315485864\ \(0\)\
\-\ mri\\:\\ 0\\.007284882578532912\ \(0\)\
\-\ origin\\:\\ 0\\.007268420452719085\ \(0\)\
\-\ those\\:\\ 0\\.007213849237122994\ \(0\)\
\-\ margins\\:\\ 0\\.007200453600808546\ \(0\)\
\-\ ependymoma\\:\\ 0\\.007096634206285273\ \(0\)\
\-\ intervention\\:\\ 0\\.007059152374527352\ \(0\)\
\-\ appearing\\:\\ 0\\.007046824837015906\ \(0\)\
\-\ in\\:\\ 0\\.007036317386386446\ \(0\)\
\-\ 60\\:\\ 0\\.006916367511566075\ \(0\)\
\-\ young\\:\\ 0\\.006904950321261106\ \(0\)\
\-\ complaints\\:\\ 0\\.006882324582682593\ \(0\)\
\-\ frequently\\:\\ 0\\.006871114351780993\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.0068160572680219635\ \(0\)\
\-\ radiology\\:\\ 0\\.006700392832819486\ \(0\)\
\-\ 40\\:\\ 0\\.00667006048031201\ \(0\)\
\-\ surgical\\:\\ 0\\.0066650158450888815\ \(0\)\
\-\ procedure\\:\\ 0\\.006640216068898978\ \(0\)\
\-\ neurologic\\:\\ 0\\.006620583212998167\ \(0\)\
\-\ motor\\:\\ 0\\.006620583212998167\ \(0\)\
\-\ references\\:\\ 0\\.006591518061338799\ \(0\)\
\-\ hyperintense\\:\\ 0\\.006581929990543915\ \(0\)\
\-\ specific\\:\\ 0\\.006553459545878497\ \(0\)\
\-\ hand\\:\\ 0\\.00651616607775032\ \(0\)\
\-\ upon\\:\\ 0\\.0064796075043192765\ \(0\)\
\-\ 25\\:\\ 0\\.006408583039437983\ \(0\)\
\-\ malformation\\:\\ 0\\.006323463177191799\ \(0\)\
\-\ solid\\:\\ 0\\.006323463177191799\ \(0\)\
\-\ \\:\\:\\ 0\\.006290954448927634\ \(0\)\
\-\ 24\\:\\ 0\\.0061641131365973096\ \(0\)\
\-\ classic\\:\\ 0\\.006074684376267295\ \(0\)\
\-\ within\\:\\ 0\\.006048725077499375\ \(0\)\
\-\ emergency\\:\\ 0\\.00600331836359977\ \(0\)\
\-\ course\\:\\ 0\\.0059824331047414496\ \(0\)\
\-\ commonly\\:\\ 0\\.0059824331047414496\ \(0\)\
\-\ 8\\:\\ 0\\.0059278618891453584\ \(0\)\
\-\ weakness\\:\\ 0\\.0058879616939302125\ \(0\)\
\-\ middle\\:\\ 0\\.0057980685893180665\ \(0\)\
\-\ risk\\:\\ 0\\.005742498418105912\ \(0\)\
\-\ nerve\\:\\ 0\\.005712330475857711\ \(0\)\
\-\ \\&\\:\\ 0\\.005568437647757758\ \(0\)\
\-\ because\\:\\ 0\\.005546416171773744\ \(0\)\
\-\ location\\:\\ 0\\.005530069920044328\ \(0\)\
\-\ benign\\:\\ 0\\.005471336488002229\ \(0\)\
\-\ headache\\:\\ 0\\.00544524199919443\ \(0\)\
\-\ neoplasm\\:\\ 0\\.0053991773208013506\ \(0\)\
\-\ flow\\:\\ 0\\.005239432053540847\ \(0\)\
\-\ back\\:\\ 0\\.005230178729772685\ \(0\)\
\-\ study\\:\\ 0\\.005216384706604748\ \(0\)\
\-\ is\\:\\ 0\\.005216055458114338\ \(0\)\
\-\ surrounding\\:\\ 0\\.005211809395852997\ \(0\)\
\-\ vascular\\:\\ 0\\.005198150775368639\ \(0\)\
\-\ should\\:\\ 0\\.0050541902446916516\ \(0\)\
\-\ t1\\:\\ 0\\.005025038100601565\ \(0\)\
\-\ enhancing\\:\\ 0\\.004972084476595101\ \(0\)\
\-\ resection\\:\\ 0\\.004944184889647901\ \(0\)\
\-\ examination\\:\\ 0\\.004928428637244091\ \(0\)\
\-\ usually\\:\\ 0\\.004814338133333504\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.004738454062421996\ \(0\)\
\-\ see\\:\\ 0\\.004731386291704617\ \(0\)\
\-\ primary\\:\\ 0\\.004696445756763815\ \(0\)\
\-\ years\\:\\ 0\\.004655367601147463\ \(0\)\
\-\ the\\:\\ 0\\.004616859229434628\ \(0\)\
\-\ s\\:\\ 0\\.004546878788709809\ \(0\)\
\-\ appearance\\:\\ 0\\.0045341494930141776\ \(0\)\
\-\ syndrome\\:\\ 0\\.0045341494930141776\ \(0\)\
\-\ t2\\:\\ 0\\.0044871776785720815\ \(0\)\
\-\ edema\\:\\ 0\\.00448408810655156\ \(0\)\
\-\ include\\:\\ 0\\.004447409068701831\ \(0\)\
\-\ a\\:\\ 0\\.004414840094455673\ \(0\)\
\-\ mass\\:\\ 0\\.004409873866224729\ \(0\)\
\-\ y\\/o\\:\\ 0\\.0043907774208156595\ \(0\)\
\-\ an\\:\\ 0\\.004384656268217922\ \(0\)\
\-\ blood\\:\\ 0\\.004327293269961595\ \(0\)\
\-\ up\\:\\ 0\\.0042631672561302845\ \(0\)\
\-\ lesions\\:\\ 0\\.004244082572066693\ \(0\)\
\-\ both\\:\\ 0\\.004048608517042897\ \(0\)\
\-\ \\(\\:\\ 0\\.004020566194307201\ \(0\)\
\-\ metastatic\\:\\ 0\\.003990926537321133\ \(0\)\
\-\ \\)\\:\\ 0\\.003971452831799472\ \(0\)\
\-\ to\\:\\ 0\\.0039616707647772385\ \(0\)\
\-\ pain\\:\\ 0\\.0038723865214498505\ \(0\)\
\-\ into\\:\\ 0\\.0037724051353612374\ \(0\)\
\-\ man\\:\\ 0\\.0037494097274397018\ \(0\)\
\-\ imaging\\:\\ 0\\.0037144226798805245\ \(0\)\
\-\ other\\:\\ 0\\.003654245915960016\ \(0\)\
\-\ this\\:\\ 0\\.0035663718490320335\ \(0\)\
\-\ it\\:\\ 0\\.003563726130859029\ \(0\)\
\-\ multiple\\:\\ 0\\.003339157705898458\ \(0\)\
\-\ lesion\\:\\ 0\\.003229230474954461\ \(0\)\
\-\ treatment\\:\\ 0\\.0032089368452706624\ \(0\)\
\-\ seen\\:\\ 0\\.003132889823873266\ \(0\)\
\-\ which\\:\\ 0\\.0029594519243832072\ \(0\)\
\-\ that\\:\\ 0\\.002738368698624904\ \(0\)\
\-\ \\.\\:\\ 0\\.0027003357699280097\ \(0\)\
\-\ on\\:\\ 0\\.0026860519939347982\ \(0\)\
\-\ by\\:\\ 0\\.0026398346998977268\ \(0\)\
\-\ of\\:\\ 0\\.0025937766411425994\ \(0\)\
\-\ as\\:\\ 0\\.0023981029793954133\ \(0\)\
\-\ with\\:\\ 0\\.0023878403283650964\ \(0\)\
\-\ ct\\:\\ 0\\.00221763201000379\ \(0\)\
\-\ history\\:\\ 0\\.0021896373612376317\ \(0\)\
\-\ old\\:\\ 0\\.0016232552817481533\ \(0\)\
\-\ patient\\:\\ 0\\.0015892243616259518\ \(0\)\
\-\ for\\:\\ 0\\.0013527052850514196\ \(0\)\
\-\ and\\:\\ 0\\.0013358738829849237\ \(0\)\
